HUMULIN 30/70 100IU/ML 3ML CARTRIDGES

Country: মাল্যাশিয়া

ভাষা: ইংরেজি

সূত্র: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

সক্রিয় উপাদান:

INSULIN, MIXED NEUTRAL/ISOPHANE (HUMAN)

থেকে পাওয়া:

ZUELLIG PHARMA SDN BHD

INN (International Name):

INSULIN, MIXED NEUTRAL/ISOPHANE (HUMAN)

প্যাকেজ ইউনিট:

3ml5Units mL

Manufactured by:

LILLY FRANCE S.A.S.

তথ্য লিফলেট

HUMULIN
® 30/70 CARTRIDGE
Human mixed insulin 100IU/ml (30% neutral, 70% isophane)
1
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What Humulin 30/70 is used for
2.
How Humulin 30/70 works
3.
Before you use Humulin 30/70
4.
How to use Humulin 30/70
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Humulin
30/70
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
11.
Serial Number
WHAT HUMULIN 30/70
IS USED FOR
Humulin
30/70
contains
the
active
substance human insulin, which is used to
treat diabetes.
Each kind of
insulin comes with its own
patient
information
leaflet
to
tell
you
about
it.
Do
not
change
your
insulin
unless your doctor tells you to. Be very
careful if you do change insulin. Each
type of
insulin has a different colour and
symbol on the pack and the cartridge so
that you can easily
tell the difference.
HOW HUMULIN 30/70 WORKS
You
get diabetes if your pancreas does
not make enough insulin to control the
level of glucose in
your blood (blood
sugar).
Humulin 30/70 is used to control glucose
in
the
long
term.
It
is
a
premixed
suspension
of
rapid
and
long
acting
insulin. Its action is prolonged by the
inclusion
of protamine sulphate in the
suspension.
BEFORE YOU USE HUMULIN 30/70
_HUMULIN _
_30/70 _
_IN _
_CARTRIDGES _
_IS _
_ONLY _
_SUITABLE FOR INJECTING JUST UNDER THE SKIN _
_USING _
_A _
_REUSABLE _
_PEN. _
_SPEAK _
_TO _
_YOUR _
_DOCTOR IF YOU NEED TO INJECT YOUR INSULIN _
_BY ANOTHER METHOD. _
-
_When you must not use it _
Do not use Humulin 30/70 if you are
allergic (hypersensitive) to human insulin
or
any
of
the
other
ingredients
of
Humulin 30/70.
_ _
_ _
_ _
_ _
-
_Before you start to use it _
DO
NOT
USE
HUMULIN
30/70
IF
YOU
THINK
HYPOGLYCAEMIA
(LOW
BLOOD
SUGAR) IS STARTING.
Further in this leaflet
it
tells
you
how
to
deal
with
mild
hypoglycaemia
If you are pregnant or lactating, ask
your doctor or diabetes specialist nurse
for advice before taking any medicine.
The amount of insulin you need usually
falls

পণ্য বৈশিষ্ট্য

Humulin N 3070 and R cartridges PI_UK SPC 20 Jul 2016_09 Jan 2017_v1
1.
NAME OF THE MEDICINAL PRODUCT
Humulin N 100 IU/ml suspension for injection in cartridge
Humulin 30/70 100 IU/ml suspension for injection in cartridge
Humulin R 100 IU/ml solution for injection in cartridge
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains 100 IU human insulin (produced in
_E. coli _
by recombinant DNA technology).
Humulin N
One cartridge contains 3 ml equivalent to 300 IU of isophane insulin.
Humulin 30/70
One cartridge contains 3 ml equivalent to 300 IU of biphasic isophane
insulin – 30 % soluble insulin /
70 % isophane insulin.
Humulin R
One cartridge contains 3 ml equivalent to 300 IU of soluble insulin.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Humulin N
A suspension for injection in a cartridge.
Humulin N is a sterile suspension of a white, crystalline precipitate
of isophane human insulin in an
isotonic phosphate buffer.
Humulin 30/70
A suspension for injection in a cartridge.
Humulin 30/70 is a sterile suspension of human insulin in the
proportion of 30 % soluble insulin to 70
% isophane insulin.
Humulin R
A solution for injection in a cartridge.
Humulin R is a sterile, clear, colourless, aqueous solution of human
insulin.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of patients with diabetes mellitus who require
insulin for the maintenance of
glucose homeostasis.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dosage should be determined by the physician, according to the
requirement of the
patient.
_Paediatric population _
No data are available
Humulin N, 3070 and R cartridges PI_EUSPC 12 Aug 2020_19 Nov 2020
Method of administration
Subcutaneous administration should be in the upper arms, thighs,
buttocks or abdomen. Use of
injection sites should be rotated so that the same site is not used
more than approximately once a
month in order to reduce the risk of lipodystrophy and cutaneous
amyloidosis (see section 4.4 and 4.8).
Care should be taken wh